Peptide services/genscript/malekzadeh
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700570P
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,598
Award facts
- Contract value 100% obligated
- $3,597.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,597.96 on August 29, 2017, for peptide services. Work is performed in San Diego, California. The order is firm fixed price with an ultimate completion date of September 30, 2017.
Quick answers
Who was awarded contract HHSN261201700570P?
HHSN261201700570P was awarded to Genscript USA Inc. by National Cancer Institute (National Institutes of Health) on August 29, 2017.
How much is contract HHSN261201700570P worth?
The government has obligated $3,598 on HHSN261201700570P.
Was contract HHSN261201700570P competed?
The extent of competition for HHSN261201700570P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award